Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report

India-based Sun Pharmaceutical Industries Ltd is reportedly evaluating a potential acquisition of Organon & Co (NYSE:OGN) , a U.S.-based women's healthcare company.If it goes through, the deal that could become the largest cross-border transaction ever by an Indian drugmaker, according to people familiar with the matter, as cited by The Economic Times.Sun Pharmaceutical has submitted a non-binding all-cash bid and arranged $10–14 billion in acquisition financing.Why It MattersIf completed, the transaction—v ...